The European Society of Cardiology Includes Neovasc Reducer(TM) for the Treatment of Refractory Angina in the European Practice Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes

Stock Information for Neovasc Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Neovasc Inc.

Shockwave Medical Completes Acquisition of Neovasc
Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update
Neovasc Shareholders Approve Acquisition by Shockwave Medical
Neovasc Announces German Reimbursement Renewal
IIROC Trade Resumption - NVCN
IIROC Trading Halt - NVCN
Shockwave Medical to Acquire Neovasc
Shockwave Medical Announces Agreement to Acquire Neovasc

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.